Navigation Links
FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
Date:11/20/2007

ower survival rates. We believe, based on the clinical research, that identifying CTCs as soon as possible can lead to improved patient outcomes."

The CellSearch test works by using antibodies that are joined to microscopic iron particles, called ferrofluid. These antibody/ferrofluid combinations attach very specifically to CTCs. Powerful magnets then "pull" the CTCs out of the blood sample. They are then stained with additional bio-molecules and chemicals so that they can be positively identified as CTCs. The CellSearch test differs from the current standard of care because it can be used much earlier than traditional imaging (e.g., CT scans), and is not subject to the variation observed with other blood tests, called serum tumor markers.

In August 2004, a clinical study using the CellSearch test in metastatic breast cancer patients was published in The New England Journal of Medicine. The authors of this study concluded "the very short median progression-free survival in patients with elevated circulating tumor cells at the first follow-up visit suggests that these patients are receiving ineffective therapy." In addition, as recently as November 2006, a metastatic breast cancer study was published in Clinical Cancer Research where the authors concluded: "The results reported here indicate that the evaluation of CTCs is an accurate measure of treatment efficacy." Additionally, the authors said: "The ability to serially quantitate and interrogate CTCs in patients with breast cancer makes possible new ways of managing and investigating the disease."

About Veridex

Veridex, LLC, a Johnson & Johnson company, develops cancer diagnostic products that will enable earlier disease detection as well as more accurate staging, monitoring and therapeutic selection. The company is initially developing two complementary product lines: CellSearch(TM) assays that identify, enumerate and characterize circulating tumor cells directly from whole blood; and Ge
'/>"/>

SOURCE Veridex, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013  Milliman, Inc., a premier global consulting ... 2013 Milliman Medical Index (MMI), which measures the healthcare ... healthcare benefits through an employer-sponsored preferred provider organization (PPO) ... in 2013 is $22,030. "For the ... on a percentage basis was the lowest in the ...
(Date:5/22/2013)... 2013  Modern Medical announced today the nationwide ... November 2012 in a test phase, ODM is ... the rising opioid abuse in the workers, compensation ... to protect employees, physicians and employers by reducing ... to provide pain relief for the injured worker.  ...
(Date:5/22/2013)... YORK , May 22, 2013 ... LLP is investigating claims on behalf of investors of ... ISRG ) (CUSIP: 46120E602) who purchased Intuitive ... 18, 2013 (the "Class Period"). Such investors are advised ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
Breaking Medicine Technology:Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2
... Feb. 21, 2012  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... King, President and Chief Executive Officer, will present at ... NY and one in Boston, MA, over the coming ...
...   Enanta Pharmaceuticals, Inc. , a research and ... drugs in the infectious disease field, announced today ... and license agreement with Novartis for the worldwide ... candidate, EDP-239, from its NS5A hepatitis C virus ...
Cached Medicine Technology:AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 3
(Date:5/22/2013)... 22, 2013 Bodybuilding.com is giving ... (May 27, 2013) Bodybuilding.com will be donating $1 from EVERY ... , “We are extremely grateful for the men and ... said Ryan DeLuca, CEO and founder of Bodybuilding.com. “It’s an ... sacrificed so much. Hire Heroes USA is an amazing organization ...
(Date:5/22/2013)... According to a May 14, 2013 US News and ... Cancer Surgery,” modern medical technology has given women with ... a whole new light. Since the new approach known as ... cancer and mastectomies with greater hope for a positive ... plastic surgery to oncology, women had little choice but to ...
(Date:5/22/2013)... Park City, UT (PRWEB) May 22, 2013 ... on the Alabama Health Insurance Exchange . Zane ... employer sponsored health benefits, is the leader in ... . , According to Zane Benefits’ website, beginning in ... health insurance coverage for individuals and small businesses will ...
(Date:5/22/2013)... in genomic health disparities from the University of Miami ... of Medicine have teamed up to hold the second ... Disparities in Genomic Medicine." The theme of this ... and government to reduce these disparities. , Despite steady ... individuals within underserved groups continue to be more vulnerable ...
(Date:5/22/2013)... Maureen Salamon HealthDay Reporter , , WEDNESDAY, May ... cause a great deal of suffering, but new research ... to something else entirely -- a smaller brain. , ... the risk of depression, scientists wanted to determine if ... difference in size -- about 2 percent -- isn,t ...
Breaking Medicine News(10 mins):Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 2Health News:Having Both Migraines, Depression May Mean Smaller Brain 3
... 2011) -- Thanks to the zebrafish, there is new hope for ... approximately 8,700 deaths each year in the United States. In ... the journal Nature , and featured on the cover, researchers ... melanoma and may play a role in up to 70 percent ...
... (Boston) - Researchers from Boston University School of Medicine ... demonstrated that a nutrient sensing pathway is involved in ... insulin resistant mice fed a diet high in fat ... in the current on-line issue of Cell Metabolism ...
... growing number of cities instituting smoking bans across the country, ... cafes to locations near college campuses, where they,ve found a ... done by researchers at Wake Forest Baptist Medical Center sheds ... discouraging. "The popularity of hookah smoking among young ...
... the newest surgical techniques can expect to be doing well ... Surgery study published online ahead of print in the [TK ... that the surgery would cause damage to the spine just ... was not the case. "Fusion for adolescent idiopathic scoliosis ...
... News) -- Sudden cardiac death kills more young athletes ... a new study. An analysis of news reports, ... Association (NCAA) revealed that one in 43,770 NCAA athletes ... at the University of Washington in Seattle. The ...
... 2011 Breast cancer survivors who experience large weight ... according to research scientists at the Kaiser Permanente Division ... cancer survivors who experienced large weight gain (10 percent ... more likely to experience a cancer recurrence compared to ...
Cached Medicine News:Health News:Researchers use zebrafish to identify new gene linked to melanoma 2Health News:Researchers use zebrafish to identify new gene linked to melanoma 3Health News:Researchers identify the metabolic signaling pathway responsible for dyslipidemia 2Health News:Hookah use widespread among college students 2Health News:Hookah use widespread among college students 3Health News:Study shows that modern surgery for scoliosis has good long-term outcomes 2Health News:Study shows that modern surgery for scoliosis has good long-term outcomes 3Health News:Sudden Cardiac Death More Common in Young Athletes Than Thought 2Health News:Large weight gain raises risk for recurrence among breast cancer survivors 2
For the quantitative determination of direct & total bilirubin in serum. Modified Malloy-Evelyn Diazotization Method. Endpoint Reaction Product measured at 540 nm. Linearity: 20 mg/dl...
... Powerwave is the first microplate spectrophotometer designed ... 7 days per week. With rugged hardware, ... Powerwave breaks the barrier of traditional spectrophotometry ... One instrument can easily read up to ...
... Spectrophotometers are simple, reliable ... use in many types ... clinical, industrial and environmental ... vial holders, Windows based ...
Spectra 3000RS & Spectra 3000RSP are very precise instruments. They have a metal base structure, durable parts for long life use, and they are very easy to use and maintain....
Medicine Products: